Relationship of dehydroepiandrosterone sulfate levels with atherosclerosis in patients with subclinical hypothyroidism
- 31 March 2021
- journal article
- research article
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 134 (1-2) , 45-50
Abstract
Summary Background Subclinical hypothyroidism is related with increased risk of cardiovascular diseases. The decreased levels of dehydroepiandrosterone sulphate (DHEA-S) are associated with hyperlipidemia, atherosclerosis and obesity. The lower levels of DHEA‑S might be an important factor in development of atherosclerosis in subclinical hypothyroidism. Methods A total of 126 patients (62 with subclinical hypothyroidism and 64 healthy individuals) were included in this prospectively designed study between January 2017 and December 2019. All individuals were evaluated according to DHEA‑S levels, carotid intima media thickness (CIMT) and anthropometric measurements. Blood samples were obtained from patients after 8 h fasting. The groups were statistically compared. Results The mean ages of control group and patients with subclinical hypothyroidism were 36.9 ± 11.0 years and 39.6 ± 11.0 years, respectively (p = 0.165). The mean waist circumferences in controls and patients were 89 ± 10.7 cm and 91.3 ± 11.1 cm, respectively (p < 0.001). The DHEA‑S levels were 131.04 ± 96.02 µg/dl in patients, and these levels were significantly decreased in patients with subclinical hypothyroidism (p = 0.024). The levels of DHEA‑S were found to be negatively correlated with CIMT (p < 0.001, c = 0.406). Conclusions The early detection of cardiac and metabolic dysfunctions in subclinical hypothyroidism is important to avoid complications. We found a negative correlation between DHEA‑S levels and metabolic and cardiovascular risk factors in subclinical hypothyroidism. We believe that our results would attract more attention to the studies investigating relationships between DHEA‑S levels and cardiovascular complications of subclinical hypothyroidism.Keywords
This publication has 32 references indexed in Scilit:
- Low Dehydroepiandrosterone Sulfate is Associated With Increased Risk of Ischemic Stroke Among WomenStroke, 2013
- DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)The Journal of Clinical Endocrinology & Metabolism, 2010
- Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish MenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Trajectories of Dehydroepiandrosterone Sulfate Predict Mortality in Older Adults: The Cardiovascular Health StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Plasma Dehydroepiandrosterone and Risk of Myocardial Infarction in WomenClinical Chemistry, 2008
- Management of Obesity in Adults: European Clinical Practice GuidelinesObesity Facts, 2008
- Dehydroepiandrosterone: Is There a Role for Replacement?Mayo Clinic Proceedings, 2003
- Dehydroepiandrosterone Reduces Plasma Plasminogen Activator Inhibitor Type 1 and Tissue Plasminogen Activator Antigen in MenThe American Journal of the Medical Sciences, 1996
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Effect of thyroidectomy on pregnenolone and progesterone biosynthesis in rat adrenal cortexThe Journal of Steroid Biochemistry and Molecular Biology, 1982